A widely used cancer drug can help women with ovarian cancer live longer, according to a new European study. Roche’s Avastin (bevacizumab) is already used for the treatment of various cancers including bowel, breast and lung cancers. A study of about 1,800 women presented during the European Society for Medical Oncology (ESMO) congress showed that the drug extended progression-free survival in women with advanced ovarian cancer to 14.1 months when taken in addition to chemotherapy versus 10.3 months with chemotherapy alone. Avastin works by inhibiting vascular endothelial growth factor (VEGF), which is thought to play a role in disease progression. ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.